Skip to main content

Table 3 Univariate logistic regression analysis of factors affecting progression to severe illness

From: Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms

 

OR

Z value

P

Use of Thymalfasin or not

0.16

-1.738

0.08

Age (65 as the demarcation)

5.661130*106

0.015

0.98

Gender

1.44

0.64

0.52

WBC (10 as the demarcation)

4.45

2.55

0.01

CRP (50 as the demarcation)

7.04

2.53

0.011

PCT (0.05 as the demarcation)

3.91

1.77

0.08

LYM (20% as the demarcation)

1.07

0.13

0.90

  1. Univariate logistic regression showed that the use of Thymalfasin was a protective factor affecting progression to critical illness, while the elevation of WBC, PCT and CRP was a risk factor